RYTM Exercise Disclosure
Meeker David P · SEC Form 4 · Filed Sep 14, 2026
Exercise
Calculated transaction value
$0
Meeker David P President And CEO
RYTM
Transaction date
Sep 14, 2026
Public filing date
Sep 14, 2026
Filing lag
Filed same day
RYTM daily price context
Close on/before transaction
$102.44
Sep 14, 2026
Close before public filing
$104.71
Sep 11, 2026
Return since public filing
-6.89%
Through Sep 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 50,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001649904-26-000026
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$5.44M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Sep 14, 2026 | $899.63K |
| Rhythm Pharmaceuticals, Inc. RYTM Current | Exercise | Sep 14, 2026 | $0 |
| Rhythm Pharmaceuticals, Inc. RYTM | Exercise | Sep 14, 2026 | $302.5K |
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Sep 14, 2026 | $655.15K |
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Sep 14, 2026 | $3.15M |
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Sep 14, 2026 | $189.96K |
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Sep 14, 2026 | $241.94K |